Cargando…
Pharmacotherapy for Essential Hypertension: A Brief Review
Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment. Among those who receive treatment, the majority remain undertreated and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733188/ https://www.ncbi.nlm.nih.gov/pubmed/36561082 http://dx.doi.org/10.14797/mdcvj.1175 |
_version_ | 1784846310082347008 |
---|---|
author | Heidari, Behnam Avenatti, Eleonora Nasir, Khurram |
author_facet | Heidari, Behnam Avenatti, Eleonora Nasir, Khurram |
author_sort | Heidari, Behnam |
collection | PubMed |
description | Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment. Among those who receive treatment, the majority remain undertreated and do not achieve their blood pressure goals. Therefore, new hypertension guidelines introduce more conscientious treatment strategies to maximize the probability of achieving the new strict blood pressure goals compared with the previous guidelines. Who should receive treatment for hypertension? Which antihypertensive medications have the strongest supporting data? Are generic and more affordable medications as effective as expensive brand medications? What are the different treatment strategies to maximize success in controlling blood pressure? Here, we briefly review pharmacotherapy for hypertension and provide answers to these questions as well as some other common questions regarding treatment of hypertension. |
format | Online Article Text |
id | pubmed-9733188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Houston Methodist DeBakey Heart & Vascular Center |
record_format | MEDLINE/PubMed |
spelling | pubmed-97331882022-12-21 Pharmacotherapy for Essential Hypertension: A Brief Review Heidari, Behnam Avenatti, Eleonora Nasir, Khurram Methodist Debakey Cardiovasc J Review Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment. Among those who receive treatment, the majority remain undertreated and do not achieve their blood pressure goals. Therefore, new hypertension guidelines introduce more conscientious treatment strategies to maximize the probability of achieving the new strict blood pressure goals compared with the previous guidelines. Who should receive treatment for hypertension? Which antihypertensive medications have the strongest supporting data? Are generic and more affordable medications as effective as expensive brand medications? What are the different treatment strategies to maximize success in controlling blood pressure? Here, we briefly review pharmacotherapy for hypertension and provide answers to these questions as well as some other common questions regarding treatment of hypertension. Houston Methodist DeBakey Heart & Vascular Center 2022-12-06 /pmc/articles/PMC9733188/ /pubmed/36561082 http://dx.doi.org/10.14797/mdcvj.1175 Text en Copyright: © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Heidari, Behnam Avenatti, Eleonora Nasir, Khurram Pharmacotherapy for Essential Hypertension: A Brief Review |
title | Pharmacotherapy for Essential Hypertension: A Brief Review |
title_full | Pharmacotherapy for Essential Hypertension: A Brief Review |
title_fullStr | Pharmacotherapy for Essential Hypertension: A Brief Review |
title_full_unstemmed | Pharmacotherapy for Essential Hypertension: A Brief Review |
title_short | Pharmacotherapy for Essential Hypertension: A Brief Review |
title_sort | pharmacotherapy for essential hypertension: a brief review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733188/ https://www.ncbi.nlm.nih.gov/pubmed/36561082 http://dx.doi.org/10.14797/mdcvj.1175 |
work_keys_str_mv | AT heidaribehnam pharmacotherapyforessentialhypertensionabriefreview AT avenattieleonora pharmacotherapyforessentialhypertensionabriefreview AT nasirkhurram pharmacotherapyforessentialhypertensionabriefreview |